Visit Website

Correvio Pharma Corp, is a speciality pharmaceutical company focused on providing innovative, high-quality brands that meet the needs of acute care physicians and patients. With a commercial presence and distribution network covering over 60 countries worldwide. Correvio develops, acquires and commercialises brands for the in-hospital, acute care market segment.

The Company’s portfolio of approved and marketed brands includes: Xydalba™ (dalbavancin hydrochloride), for the treatment of severe bacterial skin and skin structure infections (ABSSSI); Zevtera®/Mabelio® (ceftobiprole medocaril sodium), a cephalosporin antibiotic for the treatment of community- and hospital-acquired pneumonia (CAP, HAP); Brinavess® (vernakalant IV) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm. Aggrastat® (tirofiban hydrochloride) for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome. Also, Esmocard® and Esmocard Lyo® (esmolol hydrochloride), a short-acting beta-blocker used to control rapid heart rate in a number of cardiovascular indications. Correvio’s pipeline of product candidates includes Trevyent®. A drug-device combination that is designed to deliver treprostinil, the world’s leading treatment for pulmonary arterial hypertension. Correvio is traded on the NASDAQ Capital Market (CORV)

 


Arrange a Meeting

abpco 2021
Manchester Bee
Stockport Food bank
CPD Member
Living Wage Member
Good Employment - Sponsor
Good Employment - Member
Convenzis Healthcare Event testimonials

What our clients say about us

Working with Convenzis is a stress-free and a rewarding experience, with fantastic engagement from a highly targeted and relevant audience

Zoom

I worked with Convenzis, primarily Dan, for the first time this year, putting together a bespoke online event for IBM. He has always been so responsive and accommodating. The team always remained professional and helpful – despite the many demands from our side! They were very keen for us to maximise on the investment and revisit those attendees who had not committed to follow ups.
It was an absolute pleasure doing business with Convenzis and I know there will be more opportunities next year. Looking forward to it!

IBM

In view of the recent NHS Oncology Conference organised by CONVENZIS which was sponsored by Pascoe Healthcare Ltd, CONVENZIS exhibited professionalism through credible organisation, invitation of delegates/respectable Speakers and general conduct of the entire conference. This has also shown that CONVENZIS is a great partner in business which is fundamental to ROI of partnering Companies even in the wake of the pandemic.

Pascoe Healthcare

“We’ve worked with the Convenzis team for several years and their events are a regular occurrence for us. Not only is the content always extremely topical, but the speakers are always excellent and the support from the team ahead of and during the events is exceptional. The team are incredibly receptive to feedback and always goes above and beyond – a real pleasure to work with!”

eConsult

“It has been a pleasure to work with Matt and Dan for the past few events. Everything has always run smoothly and we’ve always managed to gather a large number of interested parties due to the events they have hosted.

They are also very helpful and timely in their responses, which has made working with them very easy “

Piota

Our previous experience and supporting stats

53

In-person Conferences Held

129

Virtual Conferences Held

63148

Delegates in attendance on the day

58231

Management level and above delegates

1912

Sponsorship Packages Taken

513

Number of Sponsors we have Worked with

Get Social

Stay in the loop, add our socials, and never miss an event!